Clinical Trials Directory

Trials / Completed

CompletedNCT01408277

Using Santyl on Diabetic Foot Ulcers

A Comparison of Collagenase Santyl® Ointment Used Adjunctively to Sharp Surgical Debridement and Sharp Surgical Debridement in the Care of Diabetic Foot Wounds

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
55 (actual)
Sponsor
Healthpoint · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Subjects enrolled in this study will either use Santyl daily or follow standard care procedures for up to 6 weeks for their diabetic foot wound. After 6 weeks of treatment, the subjects will continue into the follow-up phase for an additional 6 weeks. Study doctors will look at the wound in the office each week (up to 12 weeks) to see if the wound is healing. Depending on a number of factors at each office visit, the study doctors may also use a procedure called sharp debridement to remove dead skin from the wound. This study will test the hypothesis that daily treatment of diabetic foot wounds with Santyl will result in more rapid healing, healthier wounds, and fewer required sharp debridements over the study period than for diabetic foot wounds treated in other ways.

Conditions

Interventions

TypeNameDescription
BIOLOGICALSantyl2 mm Santyl applied once daily
PROCEDUREControlStandard Care

Timeline

Start date
2011-08-01
Primary completion
2012-11-01
Completion
2013-03-01
First posted
2011-08-03
Last updated
2014-07-24
Results posted
2014-05-05

Locations

7 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01408277. Inclusion in this directory is not an endorsement.